Status:
COMPLETED
Establishing Clinical Utility for a New Diagnostic Test for Patients With Shortness of Breath
Lead Sponsor:
Qure Healthcare, LLC
Collaborating Sponsors:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Conditions:
Dyspnea
Unexplained Chronic Dyspnea
Eligibility:
All Genders
Phase:
NA
Brief Summary
This study will collect high-quality data on how practicing specialist physicians, specifically cardiologists and pulmonologists, across the U.S. currently manage patients with unexplained chronic dys...
Detailed Description
This study will collect high-quality data on how practicing specialist physicians, specifically cardiologists and pulmonologists, across the U.S. currently manage patients with unexplained chronic dys...
Eligibility Criteria
Inclusion
- Board-certified cardiologist or pulmonologist for at least two years
- Averaging at least 20 hours per week of clinical and patient care duties over the last six months
- Routinely evaluate patients for unexplained or chronic dyspnea in their practice
- Practicing in the U.S.
- English speaking
- Access to the internet
- Informed, signed and voluntarily consented to be in the study
Exclusion
- Non-English speaking
- Practicing in an academic setting
- Unable to access the internet
- Not practicing in the U.S.
- Not averaging at least 20 hours per week of clinical or patient care duties over the last six months
- Do not voluntarily consent to be in the study
Key Trial Info
Start Date :
March 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2022
Estimated Enrollment :
219 Patients enrolled
Trial Details
Trial ID
NCT04693793
Start Date
March 5 2021
End Date
October 15 2022
Last Update
December 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QURE Healthcare
San Francisco, California, United States, 94109